StockStory.org on MSN3d
3 Reasons Investors Watch United Therapeutics (UTHR)United Therapeutics shares have sunk to $308.27, producing a disappointing 14% loss - worse than the S&P 500’s 1.4% drop.
We recently published a list of 20 Most Expensive Stocks Insiders Are Dumping In March. In this article, we are going to take ...
United Therapeutics Corporation (NASDAQ ... The company is also developing new treatments for PAH, gene therapy for lung blood vessels, and treatments for idiopathic pulmonary fibrosis, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results